Isabelle Borghini-Fuhrer

Director, Product Development
Research & Development
Email:
borghinii@mmv.org

Isabelle manages MMV's Pyramax project, which is MMV's second submission to the European Medicines Agency for regulatory approval. Isabelle brings to MMV her extensive experience in clinical and medical research particularly at Serono International SA. She spent 10 years in clinical development in the biotech Industry developing drugs for various indications in auto-immune diseases and hemato-oncology. She holds a PhD in Biochemistry.

Read an interview with Isabelle

Watch a feature on Isabelle produced by Radio Télévision Suisse